246 related articles for article (PubMed ID: 25015673)
1. Three patients with lafora disease: different clinical presentations and a novel mutation.
Poyrazoğlu HG; Karaca E; Per H; Gümüs H; Onay H; Canpolat M; Canöz Ö; Ozkınay F; Kumandas S
J Child Neurol; 2015 May; 30(6):777-81. PubMed ID: 25015673
[TBL] [Abstract][Full Text] [Related]
2. Four novel and two recurrent NHLRC1 (EPM2B) and EPM2A gene mutations leading to Lafora disease in six Turkish families.
Salar S; Yeni N; Gündüz A; Güler A; Gökçay A; Velioğlu S; Gündoğdu A; Hande Çağlayan S
Epilepsy Res; 2012 Feb; 98(2-3):273-6. PubMed ID: 22047982
[TBL] [Abstract][Full Text] [Related]
3. Lafora progressive myoclonus epilepsy: recent insights into cell degeneration.
Spuch C; Ortolano S; Navarro C
Recent Pat Endocr Metab Immune Drug Discov; 2012 May; 6(2):99-107. PubMed ID: 22369717
[TBL] [Abstract][Full Text] [Related]
4. Novel mutations in EPM2A and NHLRC1 widen the spectrum of Lafora disease.
Lesca G; Boutry-Kryza N; de Toffol B; Milh M; Steschenko D; Lemesle-Martin M; Maillard L; Foletti G; Rudolf G; Nielsen JE; á Rogvi-Hansen B; Erdal J; Mancini J; Thauvin-Robinet C; M'Rrabet A; Ville D; Szepetowski P; Raffo E; Hirsch E; Ryvlin P; Calender A; Genton P
Epilepsia; 2010 Sep; 51(9):1691-8. PubMed ID: 20738377
[TBL] [Abstract][Full Text] [Related]
5. Severe and rapidly-progressive Lafora disease associated with NHLRC1 mutation: a case report.
Casciato S; Gambardella S; Mascia A; Quarato PP; D'Aniello A; Ackurina Y; Albano V; Fornai F; Scala S; Di Gennaro G
Int J Neurosci; 2017 Dec; 127(12):1150-1153. PubMed ID: 28556688
[TBL] [Abstract][Full Text] [Related]
6. Clinical and genetic studies in patients with Lafora disease from Pakistan.
Ahmad A; Dad R; Ullah MI; Baig TA; Ahmad IN; Nasir A; Hübner CA; Hassan MJ
J Neurol Sci; 2017 Feb; 373():263-267. PubMed ID: 28131202
[TBL] [Abstract][Full Text] [Related]
7. Lafora progressive myoclonus epilepsy: NHLRC1 mutations affect glycogen metabolism.
Couarch P; Vernia S; Gourfinkel-An I; Lesca G; Gataullina S; Fedirko E; Trouillard O; Depienne C; Dulac O; Steschenko D; Leguern E; Sanz P; Baulac S
J Mol Med (Berl); 2011 Sep; 89(9):915-25. PubMed ID: 21505799
[TBL] [Abstract][Full Text] [Related]
8. Lafora disease in the Indian population: EPM2A and NHLRC1 gene mutations and their impact on subcellular localization of laforin and malin.
Singh S; Satishchandra P; Shankar SK; Ganesh S
Hum Mutat; 2008 Jun; 29(6):E1-12. PubMed ID: 18311786
[TBL] [Abstract][Full Text] [Related]
9. Advances in lafora progressive myoclonus epilepsy.
Delgado-Escueta AV
Curr Neurol Neurosci Rep; 2007 Sep; 7(5):428-33. PubMed ID: 17764634
[TBL] [Abstract][Full Text] [Related]
10. Lafora progressive myoclonus epilepsy: a meta-analysis of reported mutations in the first decade following the discovery of the EPM2A and NHLRC1 genes.
Singh S; Ganesh S
Hum Mutat; 2009 May; 30(5):715-23. PubMed ID: 19267391
[TBL] [Abstract][Full Text] [Related]
11. Mutations in NHLRC1 cause progressive myoclonus epilepsy.
Chan EM; Young EJ; Ianzano L; Munteanu I; Zhao X; Christopoulos CC; Avanzini G; Elia M; Ackerley CA; Jovic NJ; Bohlega S; Andermann E; Rouleau GA; Delgado-Escueta AV; Minassian BA; Scherer SW
Nat Genet; 2003 Oct; 35(2):125-7. PubMed ID: 12958597
[TBL] [Abstract][Full Text] [Related]
12. Rapidly progressive phenotype of Lafora disease associated with a novel NHLRC1 mutation.
Brackmann FA; Kiefer A; Agaimy A; Gencik M; Trollmann R
Pediatr Neurol; 2011 Jun; 44(6):475-7. PubMed ID: 21555062
[TBL] [Abstract][Full Text] [Related]
13. Clinical and genetic data on Lafora disease patients of Serbian/Montenegrin origin.
Kecmanović M; Jović N; Keckarević-Marković M; Keckarević D; Stevanović G; Ignjatović P; Romac S
Clin Genet; 2016 Jan; 89(1):104-8. PubMed ID: 25683376
[TBL] [Abstract][Full Text] [Related]
14. [Myoclonic epilepsy of Lafora: a case report].
Rudenskaia GE; Zakharova EIu; Karpin SL; Uchaev DA
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(3 Suppl 2):11-6. PubMed ID: 20873469
[TBL] [Abstract][Full Text] [Related]
15. Utilization of skin biopsy for diagnosis in a case of Lafora disease.
Rozenova KA; Lehman JS; Grande JP; Fine AL; Wieland CN
J Cutan Pathol; 2022 Oct; 49(10):885-888. PubMed ID: 35708461
[TBL] [Abstract][Full Text] [Related]
16. Mutational spectrum of the EPM2A gene in progressive myoclonus epilepsy of Lafora: high degree of allelic heterogeneity and prevalence of deletions.
Gómez-Garre P; Sanz Y; Rodríguez De Córdoba SR; Serratosa JM
Eur J Hum Genet; 2000 Dec; 8(12):946-54. PubMed ID: 11175283
[TBL] [Abstract][Full Text] [Related]
17. Lafora progressive Myoclonus Epilepsy mutation database-EPM2A and NHLRC1 (EPM2B) genes.
Ianzano L; Zhang J; Chan EM; Zhao XC; Lohi H; Scherer SW; Minassian BA
Hum Mutat; 2005 Oct; 26(4):397. PubMed ID: 16134145
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the NHLRC1 gene are the common cause for Lafora disease in the Japanese population.
Singh S; Suzuki T; Uchiyama A; Kumada S; Moriyama N; Hirose S; Takahashi Y; Sugie H; Mizoguchi K; Inoue Y; Kimura K; Sawaishi Y; Yamakawa K; Ganesh S
J Hum Genet; 2005; 50(7):347-352. PubMed ID: 16021330
[TBL] [Abstract][Full Text] [Related]
19. Lafora disease: epidemiology, pathophysiology and management.
Monaghan TS; Delanty N
CNS Drugs; 2010 Jul; 24(7):549-61. PubMed ID: 20527995
[TBL] [Abstract][Full Text] [Related]
20. Late onset Lafora disease and novel EPM2A mutations: breaking paradigms.
Jara-Prado A; Ochoa A; Alonso ME; Lima Villeda GA; Fernández-Valverde F; Ruano-Calderón L; Vargas-Cañas S; Durón RM; Delgado-Escueta AV; Martínez-Juárez IE
Epilepsy Res; 2014 Nov; 108(9):1501-10. PubMed ID: 25246353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
